Spanky,
Some background before I address PPHM. I have been investing in biotechs for 6 years and started AFTER the 1999- 2000 run up in that sector. I only invest in microcaps and try to find the next AMGN, DNA, etc. Despite having a better understanding of the science than 99% of investors, I have had quite a few blowups and have learned some hard lessons. Fortunately, I have also had four 10-30 baggers and that is all it takes to have a decent overall return despite the failures.
Now back to PPHM. Of all the stocks that I have ever followed, I am most excited about this company. The science is behind Bavituximab (Tarvacin) is evolving daily. IMO, it is an beautifully simplistic approach to target enveloped viruses and cancer cells. Of course if you follow Jazzbeermans posts, there are possible applications to a variety of protozoan and parasitic infections as well.
If Bavi does what I think it can do, you will be incredibly wealthy. I currently have a very large position and added another 15K yesterday. I have broken every investing rule in this stock with regards to diversification, but I find the story too compelling not to do so. The story has not gotten out to the mainstream, or the scientific community in general. This is great if you are building a position, but I am ready for the run. If this is not at least a 100-bagger, I will be disappointed.
News 
Market Data 
Discover 
